• 1. Recognition of amino acids by functionalized calixarenes
  Lucia Mutihac,Jae Hong Lee,Jong Seung Kim,Jacques Vicens Chem. Soc. Rev. 2011 40 2777
• 2. Helix and hairpin nucleation in short peptides using centrally positioned conformationally constrained dipeptide segments
  Siddappa Chandrappa,Subrayashastry Aravinda,Srinivasarao Raghothama,Rajesh Sonti,Rajkishor Rai,Veldore V. Harini,Narayanaswamy Shamala,Padmanabhan Balaram Org. Biomol. Chem. 2012 10 2815
• 3. Polar mixture analysis by NMR under spin diffusion conditions in viscous sucrose solution and agarose gel
  Pedro Lameiras,Simon Mougeolle,Fran?ois Pedinielli,Jean-Marc Nuzillard Faraday Discuss. 2019 218 233
• 4. Analysis of designed β-hairpin peptides: molecular conformation and packing in crystals
  Subrayashastry Aravinda,Upadhyayula S. Raghavender,Rajkishor Rai,Veldore V. Harini,Narayanaswamy Shamala,Padmanabhan Balaram Org. Biomol. Chem. 2013 11 4220
• 5. Peptide identification from a Porphyra dioica protein hydrolysate with antioxidant, angiotensin converting enzyme and dipeptidyl peptidase IV inhibitory activities
  Maria Cerme?o,Julianne Stack,Paul R. Tobin,Martina B. O'Keeffe,Pádraigín A. Harnedy,Dagmar B. Stengel,Richard J. FitzGerald Food Funct. 2019 10 3421

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Dipeptides

Introduction to H-Leu-val-OH and Its Significance in Modern Chemical Biology

H-Leu-val-OH, a compound with the CAS number 13588-95-9, represents a critical building block in the realm of chemical biology and pharmaceutical research. This dipeptide, composed of leucine (Leu) and valine (Val) linked by an amide bond and terminated with a hydroxyl group, has garnered significant attention due to its versatile applications in drug design, peptide synthesis, and biotechnological innovations.

The structural integrity and functional properties of H-Leu-val-OH make it an invaluable asset in the development of novel therapeutic agents. The presence of both hydrophobic and hydrophilic residues contributes to its solubility and stability, which are essential factors in pharmaceutical formulations. Recent advancements in computational chemistry have highlighted the potential of this compound as a scaffold for designing targeted therapies, particularly in oncology and neurodegenerative diseases.

In the context of peptide-based drug development, H-Leu-val-OH has been extensively studied for its role in modulating biological pathways. For instance, research published in leading journals such as the Journal of Medicinal Chemistry has demonstrated its efficacy in inhibiting protease enzymes that are implicated in cancer progression. The hydroxyl group at the C-terminus provides a reactive site for further chemical modifications, enabling the synthesis of more complex peptidomimetics with enhanced pharmacological profiles.

The synthesis of H-Leu-val-OH involves well-established solid-phase peptide synthesis (SPPS) techniques, which have been refined over several decades. This methodological robustness ensures high yields and purity, making it a preferred choice for industrial-scale production. Moreover, the growing interest in green chemistry has spurred efforts to optimize synthetic routes for sustainability, reducing waste and minimizing environmental impact.

Recent studies have also explored the potential of H-Leu-val-OH as a component in peptide vaccines. Its ability to elicit an immune response while maintaining structural stability makes it an attractive candidate for antigen presentation. Collaborative research between academic institutions and pharmaceutical companies has led to promising results in preclinical trials, suggesting its viability for clinical applications.

The role of H-Leu-val-OH extends beyond therapeutic applications; it is also utilized in biochemical research as a probe for understanding enzyme-substrate interactions. Its specific binding properties have been leveraged to develop high-affinity inhibitors for various enzymes, providing insights into metabolic pathways and disease mechanisms. Such findings contribute to a deeper understanding of molecular biology and open new avenues for therapeutic intervention.

As the field of chemical biology continues to evolve, the demand for high-quality peptide derivatives like H-Leu-val-OH is expected to rise. Innovations in synthetic methodologies and analytical techniques are further enhancing its utility across multiple domains. For instance, advancements in mass spectrometry have enabled precise characterization of peptide conformations, which is crucial for understanding their biological activity.

The commercial availability of H-Leu-val-OH from reputable suppliers ensures that researchers worldwide can access this compound for their studies. Regulatory compliance and quality control measures are rigorously enforced to guarantee consistency and reliability. This accessibility fosters collaborative research efforts and accelerates the translation of laboratory discoveries into clinical practice.

In conclusion, H-Leu-val-OH (CAS no. 13588-95-9) stands as a testament to the intersection of chemistry and biology, offering multifaceted applications that drive innovation in medicine and biotechnology. Its structural features, synthetic accessibility, and biological relevance position it as a cornerstone compound in modern research. As scientific understanding progresses, we can anticipate even more profound insights into its potential contributions to human health.

• 141044-61-3(D-Valine, N-[N-(5-amino-5-carboxy-1-oxopentyl)-L-valyl]-, (S)-)
• 140849-37-2(L-Isoleucine, N-(N-glycyl-L-alanyl)-, trihydrate)
• 140849-38-3(L-Isoleucine, N-(N-glycyl-L-alanyl)-, hydrate (2:1))
• 839709-75-0(L-Leucine,L-valyl-L-leucyl-L-valyl-L-leucyl-L-valyl-L-leucyl-L-valyl-L-leucyl-L-valyl-L-leucyl-L-valyl-)
• 839709-47-6(L-Leucine, L-valyl-L-leucyl-L-valyl-L-leucyl-L-valyl-L-leucyl-L-valyl-)
• 800385-67-5(L-Isoleucine, L-lysyl-L-lysyl-L-valyl-L-lysyl-L-alanyl-)
• 835653-18-4(L-Valine, L-lysylglycylglycyl-L-lysyl-L-isoleucyl-)
• 839709-73-8(L-Isoleucine, L-valyl-L-isoleucyl-L-valyl-L-isoleucyl-L-valyl-)
• 141028-29-7(L-Isoleucine, N-(N-acetyl-L-alanyl)-)
• 839709-71-6(L-Leucine, L-isoleucyl-L-leucyl-L-isoleucyl-L-leucyl-L-isoleucyl-)